الأدوية المستنشقة

Three primary inhalation devices deliver respiratory medications: nebulizers, metered-dose inhalers (MDIs), and dry-powder inhalers (DPIs). Nebulizers convert liquid medication into a fine mist for inhalation, reaching deeper respiratory tract areas. MDIs are portable handheld devices delivering precise doses with each compression. DPIs contain dry, powdered medication activated by the user's breath, eliminating coordination requirements between activation and inhalation.

Nebulizers convert liquid medication into a fine mist that reaches the deeper areas of the respiratory tract effectively. They are typically easy to use, making them suitable for individuals with severe asthma or those who struggle with manually operated inhalers. This device eliminates the coordination challenges required by other inhalation methods, ensuring consistent medication delivery.

Spacers or extenders act as medication reservoirs attached to metered-dose inhalers, simplifying administration and making the dose more predictable. They eliminate the need to coordinate breathing with device activation, which can be challenging for some patients, especially pediatric patients. This support device significantly improves medication delivery accuracy and accessibility.

Dry-powder inhalers (DPIs) are activated by the user's breath, eliminating the need to coordinate device activation and inhalation timing. This makes DPIs easier to use than metered-dose inhalers for some patients. However, DPIs have limitations: medication can clump if exposed to humidity, and patients with low lung function may struggle to inhale the powdered medicine effectively.

Patients should rinse their mouth after using inhaled medications, especially corticosteroids, to prevent oral fungal infections. Corticosteroids can create an environment in the mouth that promotes fungal growth. This simple post-inhalation hygiene practice significantly reduces the risk of developing thrush or other oral fungal complications from regular corticosteroid use.

Inhaled medications deliver drugs directly to the lungs, providing rapid onset of action and reducing systemic side effects compared to oral or injectable medications. This targeted delivery method ensures the drug reaches and is effectively absorbed in the lower respiratory tract. Direct lung delivery makes inhaled medications particularly effective for managing chronic respiratory conditions like asthma and COPD.

Common nebulized agents include bronchodilators like albuterol and anticholinergics like ipratropium. These medications are converted into a fine mist by the nebulizer, allowing them to reach deeper areas of the respiratory tract. Nebulizers effectively deliver these agents to patients with severe respiratory conditions or those unable to use manual inhalation devices.